Michael Schreck - 01 Jan 2024 Form 3 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Michael Schreck
Issuer symbol
IDXX
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
05 Jan 2024, 17:02:13 UTC
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IDXX Common Stock 535 01 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 164 Direct F1
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 160 Direct F2
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 352 Direct F3
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 791 Direct F4
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 678 Direct F5
holding IDXX Restricted Stock Unit 01 Jan 2024 Common Stock 1,005 Direct F6
holding IDXX Incentive Stock Option (right-to-buy) 01 Jan 2024 Common Stock 744 $398.49 Direct F7
holding IDXX Non-Qualified Stock Option (right-to-buy) 01 Jan 2024 Common Stock 2,769 $544.08 Direct F8
holding IDXX Incentive Stock Option (right-to-buy) 01 Jan 2024 Common Stock 324 $544.08 Direct F9
holding IDXX Non-Qualified Stock Option (right-to-buy) 01 Jan 2024 Common Stock 3,952 $505.53 Direct F10
holding IDXX Incentive Stock Option (right-to-buy) 01 Jan 2024 Common Stock 197 $505.53 Direct F11
holding IDXX Non-Qualified Stock Option (right-to-buy) 01 Jan 2024 Common Stock 4,765 $497.43 Direct F12
holding IDXX Incentive Stock Option (right-to-buy) 01 Jan 2024 Common Stock 201 $497.43 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of 659 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on September 1, 2021.
F2 Grant of 322 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022.
F3 Grant of 470 RSUs. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023.
F4 Grant of 791 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2025.
F5 Grant of 678 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.
F6 Grant of 1,005 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on February 14, 2026.
F7 Grant of option to buy 744 shares of Issuer common stock that vests in four annual installments beginning on September 1, 2021.
F8 Grant of option to buy 2,769 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2022.
F9 Grant of option to buy 324 shares of Issuer common stock that vests in one installment on February 14, 2025.
F10 Grant of option to buy 3,952 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023.
F11 Grant of option to buy 197 shares of Issuer common stock that vests in one installment on February 14, 2026.
F12 Grant of option to buy 4,765 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024.
F13 Grant of option to buy 201 shares of Issuer common stock that vests in one installment on February 14, 2027.